Large-Scale Identification of Disease Genes Involved in Acute Myeloid Leukemia

ABSTRACT Acute myeloid leukemia (AML) is a heterogeneous group of diseases in which chromosomal aberrations, small insertions or deletions, or point mutations in certain genes have profound consequences for prognosis. However, the majority of AML patients present without currently known genetic defects. Retroviral insertion mutagenesis in mice has become a powerful tool for identifying new disease genes involved in the pathogenesis of leukemia and lymphoma. Here we have used the Graffi-1.4 strain of murine leukemia virus, which causes predominantly AML, in a screen to identify novel genes involved in the pathogenesis of this disease. We report 79 candidate disease genes in common integration sites (CISs) and 15 genes whose family members previously were found to be affected in other studies. The majority of the identified sequences (60%) were not found in lymphomas and monocytic leukemias in previous screens, suggesting a specific involvement in AML. Although most of the virus integrations occurred in or near the 5′ or 3′ ends of the genes, suggesting deregulation of gene expression as a consequence of virus integration, 18 CISs were located exclusively within the genes, conceivably causing gene disruption.

[1]  Philip Lijnzaad,et al.  The Ensembl genome database project , 2002, Nucleic Acids Res..

[2]  D. Barford,et al.  TYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B* , 2001, The Journal of Biological Chemistry.

[3]  R. Nussbaum,et al.  Disrupted sperm function and fertilin beta processing in mice deficient in the inositol polyphosphate 5-phosphatase Inpp5b. , 2001, Developmental biology.

[4]  A. Berns,et al.  Proviral activation of the putative oncogene Pim‐1 in MuLV induced T‐cell lymphomas. , 1985, The EMBO journal.

[5]  J. Licht,et al.  Translocations of the RARalpha gene in acute promyelocytic leukemia. , 2001, Oncogene.

[6]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[7]  Elias S. J. Arnér,et al.  Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. , 2001, Free radical biology & medicine.

[8]  H. Um,et al.  Vitamin D3 Up-Regulated Protein 1 Mediates Oxidative Stress Via Suppressing the Thioredoxin Function1 , 2000, The Journal of Immunology.

[9]  L. Butterfield,et al.  From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. , 1999, Antioxidants & redox signaling.

[10]  J. Downing,et al.  Acute myeloid leukemia. , 1999, The New England journal of medicine.

[11]  Bo Zhou,et al.  Modulation of protein kinase signaling by protein phosphatases and inhibitors. , 2002, Pharmacology & therapeutics.

[12]  J. Licht,et al.  The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein , 2000, Molecular and Cellular Biology.

[13]  J. Rowley,et al.  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Shilatifard,et al.  An RNA Polymerase II Elongation Factor Encoded by the Human ELL Gene , 1996, Science.

[15]  B. Sefton,et al.  Transcriptional activation of lck by retrovirus promoter insertion between two lymphoid-specific promoters , 1988, Journal of virology.

[16]  E. Krebs,et al.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA , 1985, Cell.

[17]  M. Osada,et al.  Downregulation of mRNA expression of Edg-3, a putative sphingosine 1-phosphate receptor coupled to Ca2+ signaling, during differentiation of HL-60 leukemia cells. , 1998, Biochemical and Biophysical Research Communications - BBRC.

[18]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[19]  L. Girard,et al.  Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and Notch1 for oncogenesis. , 1996, Genes & development.

[20]  R. Perlmutter,et al.  Structure of the murine lck gene and its rearrangement in a murine lymphoma cell line , 1988, Molecular and cellular biology.

[21]  T. Salmi,et al.  L-myc and N-myc in hematopoietic malignancies. , 1993, Leukemia & lymphoma.

[22]  Anton Berns,et al.  Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  T. Bleu,et al.  Sphingosine 1-Phosphate-induced Cell Proliferation, Survival, and Related Signaling Events Mediated by G Protein-coupled Receptors Edg3 and Edg5* , 2000, The Journal of Biological Chemistry.

[24]  Bob Löwenberg,et al.  Large-scale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites , 2002, Oncogene.

[25]  A. Bernstein,et al.  Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus , 1985, Nature.

[26]  N. Aoki,et al.  A Cytosolic Protein-tyrosine Phosphatase PTP1B Specifically Dephosphorylates and Deactivates Prolactin-activated STAT5a and STAT5b* , 2000, The Journal of Biological Chemistry.

[27]  N. Copeland,et al.  Evi-2, a common integration site involved in murine myeloid leukemogenesis , 1990, Molecular and cellular biology.

[28]  D. Largaespada.  Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies , 2000, Leukemia.

[29]  H. Kantarjian,et al.  Prognostic significance of Tie‐1 protein expression in patients with early chronic phase chronic myeloid leukemia , 2002, Cancer.

[30]  K. Coggeshall,et al.  How do inhibitory phosphatases work? , 2002, Molecular immunology.

[31]  B. Löwenberg,et al.  Leukemic predisposition of pSca-1/Cb2 transgenic mice. , 2002, Experimental hematology.

[32]  D. Christiansen,et al.  Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities , 2002, Leukemia.

[33]  E. Rassart,et al.  Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent , 1993, Journal of virology.

[34]  J. Nick,et al.  p38 Mitogen-activated Protein Kinase-dependent and -independent Intracellular Signal Transduction Pathways Leading to Apoptosis in Human Neutrophils* , 1998, The Journal of Biological Chemistry.

[35]  S. Yamamoto,et al.  Insertional activation of N-myc by endogenous Moloney-like murine retrovirus sequences in macrophage cell lines derived from myeloma cell line-macrophage hybrids , 1989, Molecular and cellular biology.

[36]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[37]  A. Shilatifard,et al.  Molecular Basis of p53 Functional Inactivation by the Leukemic Protein MLL-ELL , 2003, Molecular and Cellular Biology.

[38]  P. Vyas,et al.  Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Licht,et al.  The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.

[40]  B. Löwenberg,et al.  Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice. , 2000, Virology.

[41]  Takuro Nakamura,et al.  Cooperative activation of Hoxa and Pbx1-related genes in murine myeloid leukaemias , 1996, Nature Genetics.

[42]  Anton Berns,et al.  Retroviral insertional mutagenesis: tagging cancer pathways. , 2003, Advances in cancer research.

[43]  S. Benchimol,et al.  Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming alleles , 1990, Molecular and cellular biology.

[44]  R. Delwel,et al.  The peripheral cannabinoid receptor, Cb2, in retrovirally-induced leukemic transformation and normal hematopoiesis. , 1998, Leukemia & lymphoma.

[45]  H. Kantarjian,et al.  High Expression of the Receptor Tyrosine Kinase Tie-1 in Acute Myeloid Leukemia and Myelodysplastic Syndrome , 2001, Leukemia & lymphoma.

[46]  D. Noh,et al.  Overexpression of peroxiredoxin in human breast cancer. , 2001, Anticancer research.

[47]  G. Weinmaster,et al.  Notch Signaling Enhances Survival and Alters Differentiation of 32D Myeloblasts1 , 2000, The Journal of Immunology.

[48]  P. Sonneveld,et al.  Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor. , 1999, Blood.

[49]  J. Shaughnessy,et al.  Leukaemia disease genes: large-scale cloning and pathway predictions , 1999, Nature Genetics.

[50]  E. Cameron,et al.  Retroviral insertion sites and cancer: fountain of all knowledge? , 2002, Cancer cell.

[51]  N. Copeland,et al.  Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines , 1988, Cell.

[52]  R. Pulido,et al.  Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents. , 2003, The Biochemical journal.

[53]  D. Grimwade,et al.  The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. , 2001, Blood.

[54]  Anthony Kerlavage,et al.  The Celera Discovery System. , 2002, Nucleic acids research.

[55]  Ruud Delwel,et al.  The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. , 2003, Blood.

[56]  L. Girard,et al.  A full-length Notch1 allele is dispensable for transformation associated with a provirally activated truncated Notch1 allele in Moloney MuLV-infected MMTVD/myc transgenic mice , 1998, Oncogene.

[57]  F. Haj,et al.  Regulation of Receptor Tyrosine Kinase Signaling by Protein Tyrosine Phosphatase-1B* , 2003, The Journal of Biological Chemistry.

[58]  A. Berns,et al.  Retroviral insertional mutagenesis as a strategy to identify cancer genes. , 1996, Biochimica et biophysica acta.

[59]  E. Rassart,et al.  Oncogene Activation in Myeloid Leukemias by Graffi Murine Leukemia Virus Proviral Integration , 1999, Journal of Virology.

[60]  K Wheatley,et al.  The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. , 1998, Blood.

[61]  J. Licht,et al.  Translocations of the RARα gene in acute promyelocytic leukemia , 2001, Oncogene.

[62]  A. Bernstein,et al.  Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[63]  R. Delwel,et al.  The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. , 2003, Blood.

[64]  T. Honjo,et al.  Murine leukemia provirus‐mediated activation of the Notch1 gene leads to induction of HES‐1 in a mouse T lymphoma cell line, DL‐3 , 1999, FEBS letters.